These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 22145501

  • 1. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W, Chaiyakum A, Pongskul C.
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [Abstract] [Full Text] [Related]

  • 2. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 3. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 4. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W.
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [Abstract] [Full Text] [Related]

  • 5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [Abstract] [Full Text] [Related]

  • 6. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
    Shastri J, Tran A, Covit A, Pepe J, Sherman RA.
    J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
    [Abstract] [Full Text] [Related]

  • 7. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
    Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC.
    Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
    [Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9. Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice.
    Toussaint ND, Pedagogos E, Beavis J, Becker GJ, Polkinghorne KR, Kerr PG.
    Nephrol Dial Transplant; 2011 Apr; 26(4):1319-26. PubMed ID: 20935019
    [Abstract] [Full Text] [Related]

  • 10. [CA-P control in haemodialysis and K/DOQI guidelines].
    Rivera F, Sánchez de la Nieta MD, Echarri R, Anaya S, Carreño A, Vozmediano MC, Alcaide MP.
    Nefrologia; 2006 Apr; 26(3):351-7. PubMed ID: 16892824
    [Abstract] [Full Text] [Related]

  • 11. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
    Wazny LD, Raymond CB, Lesperance EM, Bernstein KN.
    CANNT J; 2008 Apr; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study.
    Górriz JL, Molina P, Bover J, Barril G, Martín-de Francisco AL, Caravaca F, Hervás J, Piñera C, Escudero V, Molinero LM, en nombre de los investigadores del estudio OSERCE.
    Nefrologia; 2013 Jan 18; 33(1):46-60. PubMed ID: 23364626
    [Abstract] [Full Text] [Related]

  • 13. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul 18; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

  • 14. K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
    Wei M, Taskapan H, Esbaei K, Jassal SV, Bargman JM, Oreopoulos DG.
    Int Urol Nephrol; 2006 Jul 18; 38(3-4):739-43. PubMed ID: 17160632
    [Abstract] [Full Text] [Related]

  • 15. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.
    Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY.
    Blood Purif; 2013 Jul 18; 36(2):116-21. PubMed ID: 24217122
    [Abstract] [Full Text] [Related]

  • 16. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J, National Kidney Foundation.
    Semin Dial; 2004 Jul 18; 17(5):349-50. PubMed ID: 15461740
    [Abstract] [Full Text] [Related]

  • 17. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
    Lebner AC, Beard KM, Soroka SD, Cournoyer SH, Da Roza GA, Geary DF, Mendelssohn DC.
    Nephrol Dial Transplant; 2011 Jan 18; 26(1):156-63. PubMed ID: 20667990
    [Abstract] [Full Text] [Related]

  • 18. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Jan 18; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 19. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S.
    Hemodial Int; 2010 Jan 18; 14(1):61-7. PubMed ID: 19758297
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
    Verdalles U, García de Vinuesa S, Goicoechea M, Gómez Campderá F, Luño J.
    Nefrologia; 2007 Jan 18; 27(3):320-8. PubMed ID: 17725451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.